Genetic screening opens door to new cell therapies for Hard-to-Treat cancers
NCT ID NCT05812027
First seen Nov 17, 2025 · Last updated May 25, 2026 · Updated 19 times
Summary
This study screens up to 1,150 adults with advanced solid tumors (like head and neck, cervical, or lung cancer) to check their genetic markers. Researchers look for specific HLA types and tumor antigens to see if patients might qualify for future cell therapy trials. No treatment is given in this study—it only collects samples to find eligible participants.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Allegheny Hospitals Network
Pittsburgh, Pennsylvania, 15224, United States
-
Baylor College of Medicine
Houston, Texas, 77030, United States
-
Columbia University Herbert Irving Comprehensive Cancer Center
New York, New York, 10032, United States
-
HonorHealth Research and Innovation Institute
Scottsdale, Arizona, 85258, United States
-
Karmanos Cancer Institute
Detroit, Michigan, 48201, United States
-
Memorial Healthcare System
Hollywood, Florida, 33021, United States
-
Norton Cancer Institute
Louisville, Kentucky, 40202, United States
-
OU Health Stephenson Cancer Center
Oklahoma City, Oklahoma, 73104, United States
-
Oncology Hematology Care
Cincinnati, Ohio, 45242, United States
-
Orlando Health
Orlando, Florida, 32806, United States
-
Providence Cancer Institute Franz Clinic
Portland, Oregon, 97213, United States
-
Sarah Cannon Research Institute
Nashville, Tennessee, 37203, United States
-
The Cleveland Clinic
Cleveland, Ohio, 44195, United States
-
University of California San Diego
San Diego, California, 92037, United States
-
University of Chicago
Chicago, Illinois, 60637, United States
-
University of Miami, Sylvester Comprehensive Cancer Center
Miami, Florida, 33136, United States
-
University of Minnesota, Masonic Cancer Center
Minneapolis, Minnesota, 55455, United States
-
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, 27599, United States
-
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, 15232, United States
-
University of South Florida
Tampa, Florida, 33606, United States
-
Yale Cancer Center
New Haven, Connecticut, 06510, United States
Conditions
Explore the condition pages connected to this study.